Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 5,268 | $2.624 | $13,823 | 8,655,189 (Indirect Direct) | View |
| 2023-06-15 Sale | 2023-06-16 6:40 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $20.86 | $1,251,727 | 688,607 (Indirect Direct) | View |
| 2023-05-22 Sale | 2023-05-24 4:37 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 6,500 | $25.79 | $167,641 | 39,294 (Indirect Direct) | View |
| 2023-03-20 Sale | 2023-03-22 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 64,500 | $18.97 | $1,223,313 | 9,302,644 (Indirect Direct) | View |
| 2022-12-15 Sale | 2022-12-19 8:00 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 60,000 | $19.69 | $1,181,498 | 9,416,707 (Indirect Direct) | View |
| 2021-06-25 Sale | 2021-06-29 5:23 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary | 473,250 | $30.83 | $14,589,493 | 8,558,707 (Indirect Direct) | View |
| 2019-08-16 Purchase | 2019-08-19 4:16 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary | 974 | $8.89 | $8,659 | 9,957 (Direct) | View |
| 2019-08-14 Purchase | 2019-08-16 4:17 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President & Secretary | 2,983 | $8.6424 | $25,780 | 8,983 (Direct) | View |
| 2019-08-13 Purchase | 2019-08-14 4:15 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President & Secretary | 1,000 | $8.75 | $8,750 | 6,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 16,610 | $0 | 8,655,189 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 2,609 | $0 | 8,604,457 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 2,610 | $0 | 57,707 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 62,609 | $0 | 688,607 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0.41 | 688,607 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:33 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 15,000 | $0 | 32,894 (Direct) | View |
| 2023-03-20 Exercise | 2023-03-22 7:30 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0 | 9,302,644 (Direct) | View |
| 2023-03-20 Exercise | 2023-03-22 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0.41 | 9,302,644 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 6:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 224,000 | $0 | 8,824,457 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 6:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 10,437 | $0 | 8,824,457 (Direct) | View |
Ownership | 2023-02-14 4:41 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 0 | $0 | 8,558,707 (Indirect) | View |
| 2022-11-15 Ownership | 2023-02-14 4:41 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 145,549 | $0 | 8,558,707 (Indirect) | View |
| 2022-12-15 Exercise | 2022-12-19 8:00 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 60,000 | $0 | 9,416,707 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 8:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner | 60,000 | $0.41 | 9,416,707 (Direct) | View |
| 2022-05-14 Option Award | 2022-05-17 3:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 4:17 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 208,750 | $0 | 208,750 (Direct) | View |
Ownership | 2022-02-14 5:38 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 0 | $0 | 8,558,707 (Indirect) | View |
| 2021-04-06 Ownership | 2022-02-14 5:38 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 233,227 | $0 | 8,558,707 (Indirect) | View |
| 2021-03-25 Option Award | 2021-03-29 8:42 pm | N/A 2031-03-25 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-07-24 Ownership | 2021-02-16 5:29 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary | 265,150 | $0 | 9,020,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-28 4:15 pm | N/A 2030-05-25 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-02-24 Disposition | 2020-05-13 7:24 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary 10% Owner | 300,000 | $30.08 | 9,189,957 (Indirect) | View |
| 2019-05-23 Option Award | 2019-05-28 8:59 pm | N/A 2029-05-23 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary | 187,700 | $0 | 187,700 (Direct) | View |